| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $213.5M | — | +20.1% |
| Cost of Revenue | $86.5M | — | +8.2% |
| Gross Profit | $127.0M | — | +29.9% |
| R&D Expense | $88.6M | — | +0.4% |
| SG&A Expense | $55.5M | — | +33.3% |
| Operating Income | -$17.1M | — | +46.8% |
| Pre-tax Income | -$13.7M | — | +52.1% |
| Income Tax | $2.2M | — | +16.3% |
| Net Income | -$15.9M | — | +47.8% |
| EPS (Basic) | -$0.48 | — | +48.9% |
| EPS (Diluted) | -$0.48 | — | +48.9% |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $383.1M | +5.2% | +17.9% |
| Short-term Investments | $55.8M | -29.8% | -44.2% |
| Accounts Receivable | $77.1M | +19.5% | +48.1% |
| Inventory | $103.2M | +8.0% | +23.8% |
| Current Assets | $676.3M | +0.3% | +9.3% |
| Total Assets | $1.27B |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.9M | — | -89.7% |
| Capital Expenditures | $9.8M | — | +102.7% |
| Investing Cash Flow | $14.9M | — | +481.8% |
| Financing Cash Flow | -$956K | — | +0.2% |
| Free Cash Flow | -$4.9M | — | -111.3% |
| +3.0% |
| Current Liabilities | $132.5M | -7.9% | +10.7% |
| Total Liabilities | $167.9M | -4.0% | +4.3% |
| Stockholders' Equity | $1.10B | +0.4% | +2.8% |